Discover how smarter preclinical models are helping to bridge the critical gap between cancer research and effective patient therapies. This article highlights a scientifically-driven platform designed to translate complex cancer biology into actionable drug discovery insights.

• Modeling Tumor Heterogeneity: A diverse library of CDX models representing major cancer subtypes
• Advanced Metastasis Research: Specialized platforms that recapitulate brain and lung metastasis
• Targeted Therapy Development: Clinically aligned models for evaluating precision oncology agents
• From Insight to Impact: Reliable, translatable data to advance candidates from lab to clinic

Download the full article to explore how our scientifically grounded preclinical models can empower your cancer drug development programs.